Effect of prokinetics on the gastrointestinal transit of a capsule endoscope in healthy 4 beagles
(주)코리아스칼라
- 최초 등록일
- 2023.06.05
- 최종 저작일
- 2019.06
- 7페이지/ 어도비 PDF
- 가격 4,000원
* 본 문서는 배포용으로 복사 및 편집이 불가합니다.
서지정보
ㆍ발행기관 : 충북대학교 동물의학연구소
ㆍ수록지정보 : Journal of Biomedical and Translational Research / 20권 / 2호
ㆍ저자명 : Gyu-Dong Kim, Joong-Hyun Song, Do-Hyeon Yu, Hee-Chun Lee, Su-Jin An, Dong-In Jung, Young Joo Kim
목차
Introduction
Materials and Methods
Animals
Capsule endoscope procedure
Image analysis
Statistical analysis
Results
Baseline characteristics of the dogs
The rate of complete capsule endoscopy proceduresand gastrointestinal trasit time
Effect analysis of metoclopramide regarding thegastrointestinal transit time
Effect analysis of mirtazapine regarding the gastrointestinaltransit time
Discussion
References
영어 초록
This study investigated the prokinetic effect of metoclopramide and mirtazapine on gastric transit time (GTT), small bowel transit time (SBTT) and gastrointestinal transit time (GITT) during capsule endoscopy in four healthy beagle dogs. Four beagle dogs participated in the experiment as four groups at intervals of more than three days as the following: Control group 1 (capsule alone), Control group 2 (capsule alone), Metoclopramide administered group (metoclopramide + capsule) and Mirtazapine administered group (mirtazapine + capsule). The results of this study demonstrated there was no significant difference in GTT ([min] control group 1: 105 ± 90, control group 2: 172.5 ± 102 vs metoclopramide administered group: 247.5 ± 93, p = 0.07, 0.10) and SBTT ([min] control group 1: 120 ± 88, control group 2: 75 ± 39 vs metoclopramide administered group: 37.5 ± 15, p = 0.20, 0.18) for capsule only administered groups (control group 1 & 2) compared to metoclopramide administered group. In addition, there was no significant difference in GTT ([min] control group 1: 105 ± 90, control group 2: 172.5 ± 102 vs mirtazapine administered group: 127.5 ± 45, p = 0.56, 0.36) and SBTT ([min] control group 1: 120 ± 88, control group 2: 75 ± 39 vs mirtazapine administered group: 157.5 ± 38, p = 0.29, 0.07) between capsule only administered groups (control group 1 & 2) and mirtazapine administered group. In this study, the fact that metoclopramide might be ineffective and administration of mirtazapine might be inadequate in dogs were confirmed.
참고 자료
없음
"Journal of Biomedical and Translational Research"의 다른 논문